Orthobiologics Market

1
Pune, India, 03rd May 2019 The global
orthobiologics market is likely to gain traction
on account of rising geriatric population, which
in turn is indicative of the increasing
prevalence of chronic arthritis. Fortune
Business Insights published a report, titled
Orthobiologics Market Size, Share and Global
Trend by Product Type (Viscosupplements, Bone
Growth Stimulators, Demineralized Bone Matrix,
Synthetic Bone Substitutes, Stem Cells,
Allografts), Application (Spinal Fusion,
Maxillofacial Dental, Soft Tissue Repair,
Reconstructive Fracture Surgery), End User
(Hospitals, Ambulatory Surgical Centers,
Speciality Clinics) and Geography Forecast till
2025 which offers valuable insights into the
drivers positively impacting the global market.
As per this report, the global market for
orthobiologics was valued at US 5830.1 Mn in the
year 2018 and is anticipated to reach US 8261.6
Mn by the end of 2026. The global orthobiologics
market is projected to exhibit a CAGR of 4.5
throughout the forecast period. Get Sample
PDF https//www.fortunebusinessinsights.com/enqui
ry/request-sample-pdf/orthobiologics-market-
100173 Demand for Spinal Fusion Method Expected
to Increase A lead analyst at Fortune Business
Insights said, Spinal fusion covered the highest
share in the global orthobiologics market in
2018 owing to the rising prevalence of traumatic
injuries and accidents. The advantages offered
by orthobiologics regarding the treatment of
spine-related injuries may fuel the demand for
spinal fusion method, he continued. Another
application called soft tissue repair is
anticipated to witness highest growth on account
of escalating demand for orthobiologics in
cartilage repair. Rising incidence of sports
injuries is also responsible for driving the
soft tissue repair segment. Favorable
Reimbursement Policies Supports Growth in North
America From a geographical standpoint, North
America is expected to lead the global
orthobiologics market between 2028 and 2026. In
2018, the market for orthobiologics in North
America was valued at US 2326.2 Mn. Favourable
reimbursement policies in the U.S. and rising
adoption of advanced orthobiologics therapies
are key factors contributing to the markets
growth in the region. The rising demand for a
better quality healthcare in North America is
also expected to create growth opportunities for
the orthobiologics market in the region. Trailing
North America, Europe is the second most
prominent region, covering a significant share in
the global market for orthobiologics. Growth of
the orthobiologics market in Europe is
attributable to recent FDA approvals for
orthobiologics products. The rising demand for
viscosupplements and increasing number of
orthopaedic clinics are factors driving the
orthobiologics market in Asia Pacific. BioFiber
by Tornier and Similar Product Developments to
Boost Growth
2
The global orthobiologics market is driven by
emerging technologies in orthobiologics
treatment. For instance, a technology called 3D
printed implant offers better stability and
significantly reduces surgery time. A global
leader in orthopaedics called Tornier has
launched BioFiber Surgical Mesh. This technology
helps to repair ligament injuries and other
muscle injuries. Growing geriatric population is
another factor fuelling demand for orthobiologics
products such as orthobiologics injections. The
rising clearances for several orthobiologics
products is driving the orthobiologics market
during the forecast period. Other factors likely
to boost the orthobiologics market include
increasing demand for advanced treatment and high
growth potential especially in emerging
countries. Stringent Regulations and High Cost
May Restrict the Market to Grow Although the
orthobiologics market is growing considerably,
there are some factors that may hamper the
growth. These include high costs associated with
orthobiologics treatment. People in low-income
regions cannot afford such treatments and this
may pose a serious threat to the growth of the
orthobiologics market. Another factor hampering
the market is strict approval process for
orthobiologics treatment and products. NuVasives
Launch of Propel DBM in 2018, to Boost its Market
Position Some of the leading players presently
operating in the global orthobiologics market are
Medtronic, Stryker, Sanofi, Zimmer Biomet,
Bioventus, Sea Spine, Musculoskeletal Transplant
Foundation, Wright Medical Group N.V., and RTI
Surgical Holdings, Inc. Companies are focussing
on launching new and technologically advanced
orthobiologic products to increase their share in
the orthobiologics market. For instance,
NuVasive announced the launch of a new product
called Propel DBM in 2018. This product helps to
encourage bone growth among patients suffering
from bone disorders. Browse Complete
Report https//www.fortunebusinessinsights.com/in
dustry-reports/orthobiologics-market-100173 About
Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence,
giving a granular overview of the market they are
operating in. Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry- leading research tools and techniques
to compile comprehensive market studies,
interspersed with relevant data.
3
At Fortune Business Insights we aim at
highlighting the most lucrative growth
opportunities for our clients. We therefore
offer recommendations, making it easier for them
to navigate through technological and
market-related changes. Our consulting services
are designed to help organizations identify
hidden opportunities and understand prevailing
competitive challenges. Contact Us Fortune
Business Insights Pvt. Ltd. 308, Supreme
Headquarters, Survey No. 36, Baner, Pune-Bangalor
e Highway, Pune - 411045, Maharashtra,
India. Phone US 1 424 253 0390 UK 44 2071
939123 APAC 91 744 740 1245 Email
sales_at_fortunebusinessinsights.com